© 2022 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#triple-negative breast cancer
Trodelvy Improves Survival and Quality of Life for People With Triple-Negative Breast Cancer
3D rendering of the breast
Immunotherapy Improves Triple-Negative Breast Cancer Survival
October is Breast Cancer Awareness Month
Breast Cancer 101

Triple Negative Breast Cancer Day

Triple Negative Breast Cancer Day is only global event dedicated to triple negative breast cancer.

When Breast Cancer Spreads to the Brain: What You Need to Know

A look at the symptoms, treatments, risk factors, prognosis and research on breast cancer metastasis to the brain.
3D rendering of the breast

Cleveland Clinic Launches First-of-its-Kind Preventive Triple-Negative Breast Cancer Vaccine Study

A novel clinical trial based on research from Cleveland Clinic’s Lerner Research Institute targets triple-negative breast cancer.

New Role Discovered for Mutant Protein Found in Most Breast Cancers

An estrogen receptor known as ERα plays a critical role in more than 70% of breast cancers.

Immunotherapy for Early Breast Cancer

The Food and Drug Administration recently approved the checkpoint inhibitor Keytruda (pembrolizumab).

FDA Reconsiders Accelerated Approvals of Immunotherapy Drugs

An advisory panel reviewed follow-up data on checkpoint inhibitors, voting to maintain four approvals and rescind two.

Statins Could Improve Outcomes for People With Triple-Negative Breast Cancer

Overall survival increased by 30% among women with aggressive breast cancer who began statin use post-diagnosis.

FDA Approves Keytruda for Pre- and Post-Surgery Treatment of Early Triple-Negative Breast Cancer

This is the first immunotherapy approved for previously untreated triple-negative breast cancer that is likely to relapse.

Keytruda

Lynparza Follow-Up Treatment Delays Breast Cancer Recurrence

PARP inhibitor reduces the risk of disease recurrence in BRCA-positive people with high-risk early breast cancer.
3D rendering of the breast

FDA Approves Trodelvy for Triple-Negative Breast Cancer

The antibody-drug conjugate is the second drug approved for metastatic breast cancer in the course of a week.

Hot topics

Breast cancer self check
#metastatic breast cancer
Breast Cancer Support Groups

Trodelvy

Immunotherapy for Early Breast Cancer Improves Responses Without Worsening Quality Of Life

Study offers assurance that the benefits of the combination can be achieved without diminishing patients’ quality of life.
Cancer cells and lymphocytes

FDA Approves Keytruda Plus Chemo for Triple-Negative Breast Cancer

First-line treatment with immunotherapy and a chemotherapy regimen extended progression-free survival by 35%.
Rihanna

Young Black Breast Cancer Survivors Star in Ads for Rihanna’s Lingerie

Savage X Fenty, the pop superstar’s brand, is known for its dedication to inclusive representation in popular culture.

Immunotherapy-Chemotherapy Combo Beneficial In Triple-Negative Breast Cancer

Adding Tecentriq to a three-drug chemotherapy regimen increases odds of remission of early-stage triple-negative breast cancer.
Advertisement
Science News
Features